Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.

Honoré C, Goéré D, Messager M, Souadka A, Dumont F, Piessen G, Elias D, Mariette C; FREGAT Working Group – FRENCH.

Eur J Surg Oncol. 2013 Mar;39(3):235-41. doi: 10.1016/j.ejso.2012.12.013. Epub 2013 Jan 11.

PMID:
23313257
2.

Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.

Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C.

Ann Surg. 2009 Dec;250(6):878-87. doi: 10.1097/SLA.0b013e3181b21c7b.

PMID:
19855261
3.

Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.

Lee IS, Yook JH, Kim TH, Kim HS, Kim KC, Oh ST, Kim BS.

Eur J Surg Oncol. 2013 Feb;39(2):136-40. doi: 10.1016/j.ejso.2012.10.008. Epub 2012 Nov 11.

PMID:
23148932
4.

Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis.

Park JM, Kim SW, Nam KW, Cho YK, Lee IS, Choi MG, Chung IS, Song KY, Park CH, Jung CK.

Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1132-5. doi: 10.1097/MEG.0b013e32832a21d8.

PMID:
19369881
5.

Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.

Shi C, Yang B, Chen Q, Yang J, Fan N.

Oncology. 2011;80(5-6):289-95. doi: 10.1159/000329075. Epub 2011 Jul 18.

PMID:
21778768
6.

Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.

Chua TC, Pelz JO, Kerscher A, Morris DL, Esquivel J.

Ann Surg Oncol. 2009 Oct;16(10):2765-70. doi: 10.1245/s10434-009-0536-z. Epub 2009 Jul 30.

PMID:
19641972
7.

Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.

Fanelli MF, Silva MJ, de Paiva TF Jr, Chinen LT, Guimarães AP, Gimenes DL, Pinheiro ED, Rinck JA Jr, Nicolau UR, Sanches SM, Melo CA, Dettino AL, Cruz MR, de Melo LM, Formiga MN, de Lima VC.

Int J Clin Oncol. 2009 Aug;14(4):326-31. doi: 10.1007/s10147-008-0870-3. Epub 2009 Aug 25.

PMID:
19705243
8.

Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil.

Fanelli MF, de Paiva TF Jr, Silva MJ, Benevides CF, Guimarães AP, Gimenes DL, Pinheiro ED, Rinck JA Jr, Nicolau UR, Sanches SM, Mello CA, Dettino AL, Cruz MR, de Melo LM, Formiga MN, de Lima VC, Chinen LT.

J Surg Oncol. 2009 Nov 1;100(6):452-5. doi: 10.1002/jso.21349.

PMID:
19697363
9.

Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.

Piessen G, Messager M, Lefevre JH, Goéré D, Mabrut JY, Meunier B, Brigand C, Hamy A, Glehen O, Mariette C; FREGAT Working Group – FRENCH.

Eur J Surg Oncol. 2014 Dec;40(12):1746-55. doi: 10.1016/j.ejso.2014.04.019. Epub 2014 Jun 26.

PMID:
25012732
10.

The difference in clinic-pathological features between signet ring cell carcinoma and gastric mucinous adenocarcinoma.

Jiang H, Zhang H, Tian L, Zhang X, Xue Y.

Tumour Biol. 2013 Oct;34(5):2625-31. doi: 10.1007/s13277-013-0812-1. Epub 2013 May 1.

PMID:
23636798
11.

Clinicopathological characteristics of signet ring cell carcinoma of the stomach.

Kim DY, Park YK, Joo JK, Ryu SY, Kim YJ, Kim SK, Lee JH.

ANZ J Surg. 2004 Dec;74(12):1060-4.

PMID:
15574148
12.

Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.

Yano M, Yasuda T, Fujiwara Y, Takiguchi S, Miyata H, Monden M.

J Surg Oncol. 2004 Oct 1;88(1):39-43.

PMID:
15384086
13.

Is endoscopic resection an acceptable treatment for undifferentiated EGC?

Park J, Choi KD, Kim MY, Lee JH, Song HJ, Lee GH, Jung HY, Kim JH.

Hepatogastroenterology. 2012 Mar-Apr;59(114):607-11. doi: 10.5754/hge11467.

PMID:
21940373
14.

Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.

Kim BS, Oh ST, Yook JH, Kim BS.

Surgery. 2014 Jun;155(6):1030-5. doi: 10.1016/j.surg.2013.08.016. Epub 2014 Apr 29.

PMID:
24792508
16.

Evaluation of intraoperative intraperitoneal cytology for advanced gastric carcinoma.

Fujimoto T, Zhang B, Minami S, Wang X, Takahashi Y, Mai M.

Oncology. 2002;62(3):201-8.

PMID:
12065866
17.

Clinicopathologic features of gastric carcinoma with signet ring cell histology.

Zhang M, Zhu G, Zhang H, Gao H, Xue Y.

J Gastrointest Surg. 2010 Apr;14(4):601-6. doi: 10.1007/s11605-009-1127-9. Epub 2009 Dec 22.

PMID:
20033340
18.

Advanced gastric carcinoma with signet ring cell histology.

Li C, Kim S, Lai JF, Hyung WJ, Choi WH, Choi SH, Noh SH.

Oncology. 2007;72(1-2):64-8. Epub 2007 Nov 14.

PMID:
18004078
19.

Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.

Aoyama T, Yoshikawa T, Hayashi T, Kuwabara H, Mikayama Y, Ogata T, Cho H, Tsuburaya A.

Ann Surg Oncol. 2012 May;19(5):1568-74. doi: 10.1245/s10434-011-2158-5. Epub 2011 Dec 6.

PMID:
22143578
20.

Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma.

Yin C, Li D, Sun Z, Zhang T, Xu Y, Wang Z, Xu H.

Med Oncol. 2012 Jun;29(2):864-70. doi: 10.1007/s12032-011-9825-z. Epub 2011 Feb 5.

PMID:
21298368
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk